# Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain

> **NCT02217267** · PHASE3 · COMPLETED · sponsor: **Mahidol University** · enrollment: 29 (actual)

## Conditions studied

- Peripheral Neuropathy

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02217267
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-01
- **Primary completion:** 2017-12-29
- **Final completion:** 2018-02
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02217267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02217267, "Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02217267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*